Spire Healthcare Group (LON:SPI)‘s stock had its “sell” rating reissued by equities research analysts at Berenberg Bank in a research note issued to investors on Tuesday. They currently have a GBX 120 ($1.56) price objective on the stock. Berenberg Bank’s price target points to a potential downside of 27.05% from the company’s current price.

A number of other analysts also recently weighed in on SPI. Liberum Capital reaffirmed a “hold” rating on shares of Spire Healthcare Group in a research report on Monday, August 6th. Numis Securities reduced their target price on shares of Spire Healthcare Group from GBX 296 ($3.86) to GBX 280 ($3.65) and set a “buy” rating on the stock in a research report on Tuesday, August 7th. Peel Hunt reaffirmed an “add” rating on shares of Spire Healthcare Group in a research report on Wednesday, August 1st. Jefferies Financial Group downgraded shares of Spire Healthcare Group to a “hold” rating and reduced their target price for the stock from GBX 290 ($3.78) to GBX 160 ($2.08) in a research report on Friday, August 10th. Finally, Credit Suisse Group raised shares of Spire Healthcare Group to a “neutral” rating and reduced their target price for the stock from GBX 250 ($3.26) to GBX 215 ($2.80) in a research report on Wednesday, August 8th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of GBX 228.63 ($2.98).

Spire Healthcare Group stock traded down GBX 4.70 ($0.06) during mid-day trading on Tuesday, reaching GBX 164.50 ($2.14). 5,345,692 shares of the company traded hands, compared to its average volume of 1,770,000. Spire Healthcare Group has a 52-week low of GBX 206.40 ($2.69) and a 52-week high of GBX 362.10 ($4.72).

In other Spire Healthcare Group news, insider Peter R. Bamford bought 10,000 shares of Spire Healthcare Group stock in a transaction dated Thursday, August 9th. The shares were purchased at an average cost of GBX 161 ($2.10) per share, with a total value of £16,100 ($20,971.73).

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Featured Story: Trading Strategy Methods for Individual Investors

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.